Bespoke immunotherapy: how close are we?
Neuro Oncol
.
2019 Feb 19;21(3):289-290.
doi: 10.1093/neuonc/noz017.
Authors
Christina Jackson
1
,
Michael Lim
1
Affiliation
1
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
PMID:
31222359
PMCID:
PMC6380408
DOI:
10.1093/neuonc/noz017
No abstract available
Publication types
Comment
MeSH terms
Cancer Vaccines*
Double-Blind Method
Glioblastoma*
Humans
Immunotherapy
Vaccines, Subunit
Substances
Cancer Vaccines
Vaccines, Subunit